Securian Asset Management’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-3,513
Closed -$280K 996
2021
Q1
$280K Hold
3,513
0.01% 927
2020
Q4
$277K Sell
3,513
-100
-3% -$5.87K 0.01% 891
2020
Q3
$159K Sell
3,613
-100
-3% -$4.93K ﹤0.01% 967
2020
Q2
$164K Sell
3,713
-100
-3% -$3.73K ﹤0.01% 964
2020
Q1
$137K Hold
3,813
﹤0.01% 949
2019
Q4
$270K Sell
3,813
-312
-8% -$22.6K 0.01% 936
2019
Q3
$309K Sell
4,125
-239
-5% -$20.3K 0.01% 903
2019
Q2
$352K Buy
4,364
+2
+0% +$141 0.01% 888
2019
Q1
$292K Sell
4,362
-100
-2% -$7.57K 0.01% 927
2018
Q4
$332K Hold
4,462
0.01% 870
2018
Q3
$411K Buy
4,462
+100
+2% +$9.53K 0.01% 876
2018
Q2
$429K Hold
4,362
0.01% 849
2018
Q1
$486K Buy
+4,362
New +$489K 0.01% 782

Securian Asset Management's CMD Position: Q2 2021 in Review

Securian Asset Management sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 3,513 shares — an estimated $280K sold.

Securian Asset Management first reported a position in CMD in Q1 2018 and held it in 13 quarters. The position peaked at $486K in Q1 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • Securian Asset Management reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • Securian Asset Management sold 3,513 Cantel Medical Corporation shares in Q2 2021, an estimated $280K.
  • Securian Asset Management first reported a position in Cantel Medical Corporation in Q1 2018 and held it in 13 quarters.
  • Securian Asset Management's Cantel Medical Corporation position peaked at $486K in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Securian Asset Management's 13F filing for Q2 2021, filed 10 Aug 2021.